Literature DB >> 11435480

Transmembrane proteases in focus: diversity and redundancy?

B Bauvois1.   

Abstract

Recent advances have led to the identification and characterization of an array of transmembrane proteases that mediate the proteolysis of various substrates (including bioactive peptides, components of the extracellular matrix, and integral proteins) and cell-cell or cell-matrix adhesion. The membrane proteases known to participate in these processes currently include the ectopeptidases, the membrane-type matrix metalloproteases (MT-MMPs), the ADAM (a disintegrin and metalloprotease) family, the meprins, and the secretases, and this list may be expected to grow. The roles that these molecules play within neoplastic and inflammatory sites are being investigated actively. The capacity of these ectoenzymes to transmit intracellular-transduction signals through the plasma membrane has to be considered. An appreciation of their functional redundancy is emerging.

Mesh:

Substances:

Year:  2001        PMID: 11435480

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Arabidopsis AtCUL3a and AtCUL3b form complexes with members of the BTB/POZ-MATH protein family.

Authors:  Henriette Weber; Anne Bernhardt; Monika Dieterle; Perdita Hano; Aysegül Mutlu; Mark Estelle; Pascal Genschik; Hanjo Hellmann
Journal:  Plant Physiol       Date:  2004-12-23       Impact factor: 8.340

Review 2.  Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders.

Authors:  Stephen L Nishimura
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

3.  Inhibition of matrix metalloproteinases in Siberian hamsters impedes photostimulated recrudescence of ovaries.

Authors:  Julie Whited; Asha Shahed; Carling F McMichael; Kelly A Young
Journal:  Reproduction       Date:  2010-09-29       Impact factor: 3.906

4.  The cysteine-rich domain regulates ADAM protease function in vivo.

Authors:  Katherine M Smith; Alban Gaultier; Helene Cousin; Dominique Alfandari; Judith M White; Douglas W DeSimone
Journal:  J Cell Biol       Date:  2002-12-02       Impact factor: 10.539

Review 5.  Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?

Authors:  Emile Verhulst; Delphine Garnier; Ingrid De Meester; Brigitte Bauvois
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.